Regulator of G protein-signaling proteins and addictive drugs

Annals of the New York Academy of Sciences

Volumn 1187, Issue , 2010, Pages 341-352

  Traynor, John ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Cell signaling; Dopamine receptors; Drugs of abuse; G proteins; Opioid receptors; Opioids; RGS proteins; Stimulants

Indexed keywords

CANNABINOID RECEPTOR; CELL PROTEIN; DOPAMINE RECEPTOR; G PROTEIN COUPLED RECEPTOR; OPIATE RECEPTOR; RGS PROTEIN; RGS4 PROTEIN; RGS7 PROTEIN; UNCLASSIFIED DRUG;

ADDICTION; DRUG DEPENDENCE; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN LOCALIZATION; REVIEW;

EID: 77949286973     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2009.05150.x     Document Type: Review

References (99)

1. Berman, D.M. & Gilman. 1998. Mammalian RGS proteins: barbarians at the gate. J. Biol. Chem. 273: 1269-1272.
2. Ross, E.M. & T.M.Wilkie. 2000. GTPase-activating proteins for heterotrimeric G proteins: regulators of G protein signaling (RGS) and RGS-like proteins. Annu. Rev. Biochem. 69: 795-827.
3. De Vries, L., B. Zheng, T. Fischer, et al. 2000. The regulator of G protein signaling family. Annu. Rev. Pharmacol. Toxicol. 40: 235-271.
4. Hollinger, S. & J.R. Hepler. 2002. Cellular regulation of RGS proteins: modulators and integrators of G protein signaling. Pharmacol. Rev. 54: 527-559.
5. Traynor, J.R. & R.R. Neubig. 2005. Regulators of G protein signaling and drugs of abuse. Mol. Intervent. 5: 30-41.
6. Koob,G.F.&E.J.Nestler. 1997. The neurobiology of drug addiction. J. Neuropsychiatry Clin. Neurosci. 9: 482-497.
7. Koob, G.F., P.P. Sanna & F.E. Bloom. 1998. Neuroscience of addiction. Neuron 21: 467-476.
8. Kenny, P.J.&A.Markou. 2004. The ups and downs of addiction: role of metabotropic glutamate receptors. Trends Pharmacol. Sci. 25: 265-272.
9. Tesmer, J.J., D.M. Berman, A.G. Gilman, et al. 1997. Structure of RGS4 bound to AlF4-activated G(i alpha1): stabilization of the transition state for GTP hydrolysis. Cell 89: 251-261.
10. Clark, M.J., C. Harrison, H. Zhong, et al. 2003. Endogenous RGS protein action modulatesmu-opioid signaling through Galphao. Effects on adenylyl cyclase, extracellular signal-regulated kinases, and intracellular calcium pathways. J. Biol. Chem. 278: 9418-9425.
11. Martemyanov, K.A., P.J. Yoo, N.P. Skiba, et al. 2005. R7BP, a novel neuronal protein interacting with RGS proteins of the R7 family. J. Biol. Chem. 280: 5133-5136.
12. Ballon, D.R., P.L. Flanary, D.P. Gladue, et al. 2006. DEP-domain-mediated regulation ofGPCRsignaling responses. Cell 126: 1079-1093.
13. Drenan, R.M., C.A. Doupnik, M.P. Boyle, et al. 2005. Palmitoylation regulates plasma membrane-nuclear shuttling of R7BP, a novel membrane anchor for the RGS7 family. J. Cell Biol. 169: 623-633.
14. Song, J.H., J.J.Waataja & K. A.Martemyanov. 2006. Subcellular targeting of RGS9-2 is controlled by multiple molecular determinants on itsmembrane anchor, R7BP. J. Biol. Chem. 281: 15361-15369.
15. Witherow, D.S., Q. Wang, K. Levay, et al. 2000. Complexes of the G protein subunit G-5 with the regulators ofGprotein signaling RGS7 and RGS9. Characterization in native tissues and in transfected cells. J. Biol. Chem. 275: 24872-24880.
16. Chen, C.K., P. Eversole-Cire, H. Zhang, et al. 2003. Instability of GGL domain-containing RGS proteins in mice lacking theGprotein beta-subunitG-5. Proc.Natl.Acad. Sci. USA 100: 6604-6609.
17. Balasubramanian, N., K. Levay, T. Keren-Raifman, et al. 2001. Phosphorylation of the regulator of G protein signaling RGS9-1 by protein kinase A is a potential mechanism of light- and Ca2+-mediated regulation of G protein function in photoreceptors. Biochemistry 40: 12619-12627.
18. Hollinger, S., S. Ramineni & J.R. Hepler. 2003. Phosphorylation of RGS14 by protein kinase A potentiates its activity toward G-i. Biochemistry 42: 811-819.
19. Jones, T.L. 2004. Role of palmitoylation in RGS protein function. Meth. Enzymol. 389: 33-55.
20. Popov, S.G., U.M. Krishna, J.R. Falck, et al. 2000. Ca2+/calmodulin reverses phosphatidylinositol 3,4,5- trisphosphate-dependent inhibition of regulators of G protein signaling GTPase-activating protein activity. J. Biol. Chem. 275: 18962-18968.
21. Ishii, M., S. Fujita, M. Yamada, et al. 2005. Phosphatidylinositol 3,4,5-trisphosphate and Ca2+/calmodulin competitively bind to the regulators of G-protein-signaling (RGS) domain of RGS4 and reciprocally regulate its action. Biochem. J. 385: 65-73.
22. Day, P.W., J.J. Tesmer, R. Sterne-Marr, et al. 2004. Characterization of the GRK2 binding site of G-q. J. Biol. Chem. 279: 53643-53652.
23. Kozasa, T., X. Jiang, M.J.Hart, et al. 1998. p115 RhoGEF, a GTPase activating protein for Galpha12 and Galpha13. Science 280: 2109-2111.
24. Booden, M.A., D.P. Siderovski & C.J. Der. 2001. Leukemia-associated Rho guanine nucleotide exchange factor promotes G-q-coupled activation of RhoA. Mol. Cell. Biol. 22: 4053-4061.
25. Linseman, D. A., F.A. Loucks & F. Alexandra. 2008. Diverse roles of Rho family GTPases in neuronal development, survival, and death. Front. Biosci. 13: 657-676.
26. Lan, K.L., H. Zhong, M. Nanamori, et al. 2000. Rapid kinetics of regulator of G-protein signaling (RGS)- mediated Galphai and Galphao deactivation. Galpha specificity of RGS4 and RGS7. J. Biol. Chem. 275: 33497-33503.
27. Posner, B.A., A.G. Gilman & B.A. Harris. 1999. Regulators of G protein signaling 6 and 7. Purification of complexes with G-5 and assessment of their effects on G protein-mediated signaling pathways. J. Biol. Chem. 274: 31087-31093.
28. Heximer, S.P., N. Watson, M.E. Linder, et al. 1997. RGS2/GOS8 is a selective inhibitor of G-q function. Biochemistry 94: 14389-14393.
29. Xu, X., W. Zeng, S. Popov, et al. 1999. RGS proteins determine signaling specificity of Gq-coupled receptors. J. Biol. Chem. 274: 3549-3556.
30. Wang, Q., M. Liu, B. Mullah, et al. 2002. Receptorselective effects of endogenous RGS3 and RGS5 to regulate mitogen-activated protein kinase activation in rat vascular smooth muscle cells. J. Biol. Chem. 277: 24949-24958.
31. Bernstein, L.S., S. Ramineni, C. Hague, et al. 2004. RGS2 binds directly and selectively to theM1muscarinic acetylcholine receptor third intracellular loop to modulate Gq/11alpha signaling. J. Biol. Chem. 279: 21248-21256.
32. Saitoh,O., Y.Murata,M.Odagiri, et al. 2002. Alternative splicing of RGS8 gene determines inhibitory function of receptor type-specific Gq signaling. Proc. Natl. Acad. Sci. USA 99: 10138-10143.
33. Wang, Q., L.Y. Liu-Chen & J.R. Traynor. 2009. Differential modulation of -- and --opioid receptor agonists by endogenous RGS4 protein in SH-SY5Y cells. J. Biol. Chem. 284: 18357-18367.
34. Grafstein-Dunn, E., K.H. Young, M.I. Cockett, et al. 2001. Regional distribution of regulators of G-protein signaling (RGS) 1,2,13,14,16 and GIAP messenger ribonucleic acids by in situ hybridization in rat brain. Mol. Brain Res. 88: 113-123.
35. Taymans, J.M., C.Wintermolders, P. Te Reile, et al. 2002. Detailed localization of regulator ofGprotein signaling 2 messenger ribonucleic acid and protein in the rat brain. Neurosci. 1: 1439-1453.
36. Gold, S.J., Y.G. Ni,H.G. Dohman, et al. 1997. Regulators of G-protein signaling (RGS) proteins; region-specific expression of nine subtypes in rat brain. J. Neurosci. 17: 8024-8037.
37. Nomoto, S., K. Adachi, L-X. Yang, et al. 1997. Distribution of RGS4 mRNA in mouse brain shown by in situ hybridization. Biochem. Biophys. Res. Commun. 241: 281-287.
38. Colantuoni, C., T.M. Hyde, S. Mitkus, et al. 2008. Agerelated changes in the expression of schizophrenia susceptibility genes in the human prefrontal cortex. Brain Struct. Funct. 213: 255-271.
39. Mirnics, K., F.A.Middelton, G.D. Stanwood, et al. 2001. Disease-specific changes in regulator ofG-protein signaling 4 (RGS4) expression in schizophrenia.Mol. Psychiat. 6: 293-301.
40. Erdely, H.A., C.A. Tamminga, R.C. Roberts, et al. 2006. Regional alterations in RGS4 protein in schizophrenia. Synapse 59: 472-479.
41. Gu, Z., Q. Jiang & Z. Yan. 2007. RGS4 modulates serotonin signaling in prefrontal cortex and links to serotonin dysfunction in a rat model of schizophrenia. Mol. Pharmacol. 71: 1030-1039.
42. Granneman, J.G., Y. Zhai, Z. Zhu, et al. 1998.Molecular characterization of human and rat RGS9L, a novel splice variant enriched in dopamine target regions, and chromosomal localization of the RGS9 gene.Mol. Pharmacol. 54: 687-694.
43. Thomas, E.A., P.E. Danielson & J.G. Sutcliffe. 1998. RGS9: a regulator of G protein signaling with specific expression in rat and mouse striatum. J. Neurosci. Res. 52: 118-124.
44. Rahman, Z., S.J. Gold, P. Potenza, et al. 1999. Cloning and characterization of RGS9-2, a striatal-enriched alternatively spliced product of the RGS9 gene. J. Neurosci. 19: 2016-2026.
45. Greengard, P., P.B. Allen & A.C. Nairn. 1999. Beyond the dopamine receptor: the DARPP-32/protein phosphatase-1 cascade. Neuron 23: 435-447.
46. Zachariou, V., D. Georgescu, N. Sanchez, et al. 2003. Essential role for RGS9 in opiate action. Proc. Natl. Acad. Sci. USA 100: 13656-13661.
47. Burchett, S.A.,M.L. Volk, M.J. Bannon, et al. 1998. Regulators of G protein signaling: rapid changes in mRNA abundance in response to amphetamine. J. Neurochem. 70: 2216-2219.
48. Bodenstein, J., R.K. Sunahara & R.R. Neubig. 2007. Nterminal residues control proteasomal degradation of RGS2, RGS4, and RGS5 in human embryonic kidney 293 cells. Mol. Pharmacol. 71: 1040-1050.
49. Graybeil, A.M.N., R.Moratalla & H.A. Robertson. 1990. Amphetamine and cocaine induce drug-specific activation of the c-fos gene in striosome-matrix compartments and limbic subdivisions of the striatum. Proc.Natl. Acad. Sci USA 87: 6912-6916.
50. Burchett, S.A., M.J. Bannon & J.G. Granneman. 1999. RGS mRNA expression in rat striatum: modulation by dopamine receptors and effects of repeated amphetamine administration. J. Neurochem. 72: 1529-1533.
51. Siderovski, D.P., S.P. Heximer & D.R. Forsdyke. 1994. A human gene encoding a putative basic helix-loop- helix phosphoprotein whose mRNA increases rapidly in cycloheximide-treated blood mononuclear cells. DNA Cell Biol. 13: 125-147.
52. Thirunavukkarasu, K., D.L. Halladay, R.R. Miles, et al. 2002. Analysis of regulator of G-protein signaling-2 (RGS-2) expression and function in osteoblastic cells. J. Cell. Biochem. 85: 837-850.
53. Taymans, J.-M., J.E. Leysen & X. Langlois. 2003. Striatal gene expression of RGS2 and RGS4 is specifically mediated by dopamine DI and D2 receptors: clues for RGS2 and RGS4 functions. J. Neurochem. 84: 1118-1127.
54. Ingi, T., A.M. Krumins, P. Chidiac, et al. 1998. Dynamic regulation of RGS2 suggests a novel mechanism in G protein signaling and neuronal plasticity. J. Neurosci. 18: 7178-7188.
55. Salim, S., S. Sinnarajah, J.H. Kehrl, et al. 2003. Identification of RGS2 and type V adenylyl cyclase interaction sites. J. Biol. Chem. 278: 15842-15849.
56. Roy, A.A., A. Baragli, L.S. Bernstein, et al. 2006. RGS2 interacts with Gs and adenylyl cyclase in living cells. Cell. Signal. 18: 336-348.
57. Sinnarajah, S., C.W. Dessauer, D. Srikumar, et al. 2001. RGS2 regulates signal transduction in olfactory neurons by attenuating activation of adenylyl cyclase III. Nature 409: 1051-1055.
58. Labouebe, G., M. Lomazzi, H.G. Cruz, et al. 2007. RGS2 modulates coupling between GABAB receptors and GIRK channels in dopamine neurons of the ventral tegmental area. Nat. Neurosci. 12: 1559-1568.
59. Gold, S.J., M.-H. Han, A.E. Herman, et al. 2003. Regulation of RGS proteins by chronic morphine in rat locus coeruleus. Eur. J. Neurosci. 17: 971-980.
60. Davydov I.V. & A. Varshavsky. 2000. RGS4 is arginylated and degraded by theN-end rule pathway in vitro. J. Biol. Chem. 275: 22931-22941.
61. Ni, Y.G., S.J. Gold, P.A. Iredale, et al. 1999. Regionspecific regulation of RGS4 (regulator of G-proteinsignaling protein type 4) in brain by stress and glucocorticoids: in vivo and in vitro studies. J. Neurosci. 19: 3674-3680.
62. Nakagawa, T., M. Mimami & M. Satoh. 2001. Upregulation of RGS4 mRNA by opioid receptor agonists in PC12 cells expressing mu- or kappa- receptors. Eur. J. Pharmacol. 433: 29-36.
63. Bishop, G.B., W.E. Cillinan, E. Curran, et al. 2002. Abused drugsmodulate RGS4 mRNA levels in rat brain: comparison between acute drug treatment and a drug challenge after chronic treatment. Neurobiol. Dis. 10: 334-343.
64. Befort, K., D. Filliol, E. Darcq, et al. 2008. Gene expression is altered in the lateral hypothalamus upon activation of themu opioid receptor. Ann. N. Y.Acad. Sci. 1129: 175-184.
65. Georgoussi, Z., L. Leontiadis, G.Mazarakou, et al. 2006. Selective interaction between G protein subunits and RGS4with theC-terminal domains of the-and --opioid receptors regulate opioid receptor signaling. Cell. Signal. 18: 771-782.
66. Grillet, N., A. Pattyn, C. Contet, et al. 2002. Generation and characterization of RGS4 mutant mice. Mol. Cell. Biol. 25: 4221-4228.
67. Zachariou, V., W. Renthal, S.J. Gold, et al. 2006. RGS4 modulates morphine reward and dependence. Soc. Neurosci. Abst. 32: 724.
68. Schwendt, M., S.J. Gold & J.F. McGinty. 2006. Acute amphetamine down-regulates RGS4 mRNA and protein expression in rat forebrain: distinct roles for D1 and D2 receptors. J. Neurochem. 96: 1606-1615.
69. Yuferov, V., T. Kroslak, K.S. Laforge, et al. 2003. Differential gene expression in the rat caudate putamen after 'binge' cocaine administration: advantage of triplicate microarray assays. Synapse 48: 157-169.
70. Zhang, D., L. Zhang, Y. Tang, et al. 2005. Repeated cocaine administration induced gene expression changes through the dopamine D1 receptors. Neuropsychopharmacology 30: 1443-1454.
71. Schwendt, M., M.C. Hearing, R.E. See, et al. 2007. Chronic cocaine reduced RGS4 mRNA in rat prefrontal cortex and dorsal striatum. Neuroreport 18: 1261-1265.
72. Crespo, J.A., J.M. Oliva, M.B. Ghasemzadeh, et al. 2002. Neuroadaptive changes inNMDAR1 gene expression after extinction of cocaine self-administration. Ann. N. Y. Acad. Sci. 965: 78-91.
73. Psifogeorgou, K., P. Papakosta, S.J. Russo, et al. 2007. RGS9-2 is a negative modulator of --opioid receptor function. J. Neurochem. 103: 617-625.
74. Kim, E., T. Arnoult, L. Sellin, et al. 1999. Interaction between RGS7 and polycystin. Proc. Natl. Acad. Sci. USA 96: 6371-6376.
75. Garz ́ on, J., M. Rodŕ?guez-D́?az, A.P Ĺopez-Fando, et al. 2001. RGS9 proteins facilitate acute tolerance to muopioid effects. Eur. J. Neurosci. 13: 801-811.
76. Garz ́ on, J., A. Ĺopez-Fando&P. Sanchez-Blanquez. 2003. The R7 family of RGS proteins assists tachyphylaxis and acute tolerance at --opioid receptors. Neuropsychopharmacol. 28: 1983-1990.
77. Rahman, Z., J. Schwarz, S.J.Gold, et al. 2003. RGS9 modulates dopamine signaling in the basal ganglia. Neuron 38: 941-952.
78. Jiang, M., K. Spicher, G. Boulay, et al. 2001.Most central nervous system D2 dopamine receptors are coupled to their effectors by Go.Proc. Natl.Acad. Sci. USA98: 3577-3582.
79. Kovoor, A., P. Seyffarth, J. Ebert, et al. 2005. D2 dopamine receptors colocalize regulator of G-protein signaling 9-2 (RGS9-2) via the RGS9 DEP domain, and RGS9 knock-out mice develop dyskinesias associated with dopamine pathways. J. Neurosci. 25: 2157-2165.
80. Gold, S.J., C.V. Hoang, B.W. Potts, et al. 2007. RGS9- 2 negatively modulates l-3,4-dihydroxyphenylalanineinduced dyskinesia in experimental Parkinson's disease. J. Neurosci. 27: 14338-14348.
81. Sharifi, J.L., D.L. Brady & J.I. Koenig. 2004. Estrogen modulates RGS9 expression in the nucleus accumbens. Neuroreport 15: 2433-2436.
82. Becker, J.B. 1999. Gender differences in dopaminergic function in striatum and nucleus accumbens. Pharmacol. Biochem. Behav. 64: 803-812.
83. Kuno, O., J.K. Kane, T. Barrett, et al. 2001. Regionspecific transcriptional response to chronic nicotine in rat brain. Brain Res. 909: 194-203.
84. Vadasz, C., M. Saito, D. O'Brien, et al. 2007. Ventral tegmental transcriptome response to intermittent nicotine treatment and withdrawal in BALB/cJ, C57BL/6ByJ and quasi-congenic RQI mice. Neurochem. Res. 32: 457-480.
85. Wang, J., R. Gutala, Y.Y. Hwang, et al. 2008. Strain-and region-specific gene expression profiles in mouse brain in response to chronic nicotine treatment. Genes Brain Behav. 7: 78-87.
86. Ajit, S.K., S. Ramineni, W. Edris, et al. 2007. RGSZ1 interacts with protein kinase C interacting protein PKC- 1 and modulates- opioid receptor signaling. Cell. Signal. 19: 723-730.
87. Garzon, J., M. Rodriguez-Munoz, A. Lopez-Fabnos, et al. 2004. RGSZ1 and GAIP regulate -- but not --opioid receptors in mouse cns: role in tachyphylaxis and acute tolerance. Neuropsychopharmacology 29: 1091-1104.
88. Hashimoto, J.G. & K.M. Wirren. 2008. Neurotoxic consequenes of chronic alcohol withdrawal: expression profiling reveals importance of gender over withdrawal severity. Neuropsychopharmacology 33: 1084-1096.
89. Soundararajan, M., F.S.Willard, A.J. Kimple, et al. 2008. Structural diversity in the RGS domain and its interaction with heterotrimeric G protein --subunits. Proc. Natl. Acad. Sci. USA 105: 6457-6462.
90. Roman, D.L., J.N. Talbot, R.A. Roof, et al. 2007. Identification of small-molecule inhibitors of RGS4 using a high-throughput flow cytometry protein interaction assay. Mol. Pharmacol. 71: 169-175.
91. Young, K.H., Y.Wang, C. Bender, et al. 2004. Yeast-based screening for inhibitors of RGS proteins. Meth. Enzymol. 389: 277-301.
92. Roof, R.A., K. Sobczyk-Kojiro, A. J. Turbiak, et al. 2008. Novel peptide ligands of RGS4 froma focused one-bead, one-compound library. Chem. Biol. Drug Des. 72: 111-119.
93. Jin, Y., H. Zhong, J.R. Omnaas, et al. 2004. Structurebased design, synthesis, and pharmacologic evaluation of peptide RGS4 inhibitors. J. Peptide Res. 63: 141-146. (Pubitemid 38333842)
94. Clark, M.J., J.J. Linderman & J.R. Traynor. 2008. Endogenous RGS proteins differentially modulate full and partial mu agonists at adenylyl cyclase: the role of G protein kinetics in agonist efficacy. Mol. Pharmacol. 73: 1538-1548.
95. Neubig, R.R. & D.P. Siderovski. 2002. Regulators of Gprotein signalling as new central nervous system drug targets. Nat. Rev. Drug Discov. 1: 187-197.
96. Cifelli, C., R.A. Rose, H. Zhang, et al. 2008. RGS4 regulates parasympathetic signaling and heart rate control in the sinoatrial node. Circ. Res. 103: 527-535.
97. Heximer, S.P., R.H. Knutsen, X. Sun, et al. 2003. Hypertension and prolonged vasoconstrictor signaling in RGS2-deficient mice. J. Clin. Invest. 111: 445-452.
98. Clark M.J. & J.R. Traynor. 2004. Assays for G-proteincoupled receptor signaling using regulators of G-proteins signaling-insensitive G- subunits. Meth. Enzymol. 389: 155-169.
99. Huang, X., Y. Fu, R.A. Charbeneau, et al. 2006. Pleiotropic phenotype of a genomic knock-in of an RGSinsensitive G184S Gnai2 allele. Mol. Cell. Biol. 26: 6870-6879.